BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32119835)

  • 1. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.
    Yao Y; Yang D; Huang Y; Dong M
    Clin Chim Acta; 2020 Jun; 505():141-147. PubMed ID: 32119835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.
    Chawla YK; Kashinath RC; Duseja A; Dhiman RK
    J Clin Exp Hepatol; 2011 Dec; 1(3):161-8. PubMed ID: 25755381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland.
    Bie CQ; Yang DH; Tang SH; Huang W
    Hepatol Res; 2009 Aug; 39(8):779-85. PubMed ID: 19473429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.
    Huber Y; Bierling F; Labenz C; Koch S; Schmidtmann I; Kloeckner R; Schotten S; Huber T; Lang H; Woerns MA; Galle PR; Weinmann A; Weinmann-Menke J
    BMC Cancer; 2018 Jul; 18(1):774. PubMed ID: 30064393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adding variceal status to the Child-Turcotte-Pugh score improve its performance in predicting mortality in cirrhosis?
    Fan X; Wen M; Shen Y; Wang W; Yang X; Yang L
    Medicine (Baltimore); 2016 Sep; 95(38):e4884. PubMed ID: 27661030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices.
    Radisavljević M; Bjelaković G; Jović J; Radovanović-Dinić B; Benedoto-Stojanov D; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2017 Jan; 74(1):13-8. PubMed ID: 29350501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
    Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
    J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy.
    Wu SL; Zheng YX; Tian ZW; Chen MS; Tan HZ
    World J Clin Cases; 2018 Dec; 6(15):995-1006. PubMed ID: 30568954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    Lee DH; Lee JH; Jung YJ; Gim J; Kim W; Kim BG; Lee KL; Cho Y; Yoo JJ; Lee M; Cho YY; Cho EJ; Yu SJ; Kim YJ; Yoon JH
    PLoS One; 2017; 12(1):e0170394. PubMed ID: 28107416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
    Kaseb AO; Xiao L; Hassan MM; Chae YK; Lee JS; Vauthey JN; Krishnan S; Cheung S; Hassabo HM; Aloia T; Conrad C; Curley SA; Vierling JM; Jalal P; Raghav K; Wallace M; Rashid A; Abbruzzese JL; Wolff RA; Morris JS
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].
    Jeong JY; Sohn JH; Son BK; Paik CH; Kim SH; Han DS; Jeon YC; Lee MH; Lee DH; Kee CS
    Korean J Gastroenterol; 2007 Feb; 49(2):93-9. PubMed ID: 17322788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.